326 related articles for article (PubMed ID: 12796257)
41. Mutant-type alpha5(IV) collagen in a mild form of Alport syndrome has residual ability to form a heterotrimer.
Kobayashi T; Uchiyama M
Pediatr Nephrol; 2010 Jun; 25(6):1169-72. PubMed ID: 20130921
[TBL] [Abstract][Full Text] [Related]
42. Gene symbol: COL4A5. Disease: Alport syndrome.
Neri TM; Sebastio P
Hum Genet; 2005 Dec; 118(3-4):543. PubMed ID: 16521290
[No Abstract] [Full Text] [Related]
43. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
44. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
Liang L; Wu H; Cai Z; Zhao J
BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645
[TBL] [Abstract][Full Text] [Related]
45. Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome.
Wei G; Zhihong L; Huiping C; Caihong Z; Zhaohong C; Leishi L
Nephrol Dial Transplant; 2006 Nov; 21(11):3146-54. PubMed ID: 16940319
[TBL] [Abstract][Full Text] [Related]
46. Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy.
Mothes H; Heidet L; Arrondel C; Richter KK; Thiele M; Patzer L; Sado Y; Gubler MC; Antignac C; Scheele J
Nephrol Dial Transplant; 2002 Jan; 17(1):70-4. PubMed ID: 11773466
[TBL] [Abstract][Full Text] [Related]
47. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
Wang F; Wang Y; Ding J; Yang J
Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
[TBL] [Abstract][Full Text] [Related]
48. Electron microscopic examination of the anterior lens capsule in a case of Alport's syndrome.
Citirik M; Batman C; Men G; Tuncel M; Zilelioglu O
Clin Exp Optom; 2007 Sep; 90(5):367-70. PubMed ID: 17697183
[TBL] [Abstract][Full Text] [Related]
49. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
Wang F; Zhang YQ; Ding J; Yu LX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
[TBL] [Abstract][Full Text] [Related]
50. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
Chen N; Pan X; Ren H; Dong D
Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
[TBL] [Abstract][Full Text] [Related]
51. [Anterior lenticonus: diagnostic aid in Alport syndrome].
Blaise P; Delanaye P; Martalo O; Pierard GE; Rorive G; Galand A
J Fr Ophtalmol; 2003 Dec; 26(10):1075-82. PubMed ID: 14691404
[TBL] [Abstract][Full Text] [Related]
52. A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.
Baikara BT; Zholdybayeva EV; Rakhimova SE; Nigmatullina NB; Momynaliev KT; Ramanculov YM
PLoS One; 2015; 10(7):e0132010. PubMed ID: 26168235
[TBL] [Abstract][Full Text] [Related]
53. Gene symbol: COL4A5. Disease: Alport Syndrome.
Savige J; Tan R; Colville D; Wang Y; Parkin JD; Mathew N; Savige J
Hum Genet; 2008 Oct; 124(3):301. PubMed ID: 18846626
[No Abstract] [Full Text] [Related]
54. A novel COL4A5 mutation identified in a Chinese Han family using exome sequencing.
Xiu X; Yuan J; Deng X; Xiao J; Xu H; Zeng Z; Guan L; Xu F; Deng S
Biomed Res Int; 2014; 2014():186048. PubMed ID: 25110662
[TBL] [Abstract][Full Text] [Related]
55. Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.
Wang Y; Zhang H; Ding J; Wang F
Exp Biol Med (Maywood); 2007 May; 232(5):638-42. PubMed ID: 17463160
[TBL] [Abstract][Full Text] [Related]
56. Effect of glycine substitutions on alpha5(IV) chain structure and structure-phenotype correlations in Alport syndrome.
Wang YF; Ding J; Wang F; Bu DF
Biochem Biophys Res Commun; 2004 Apr; 316(4):1143-9. PubMed ID: 15044104
[TBL] [Abstract][Full Text] [Related]
57. COL4A6 is dispensable for autosomal recessive Alport syndrome.
Murata T; Katayama K; Oohashi T; Jahnukainen T; Yonezawa T; Sado Y; Ishikawa E; Nomura S; Tryggvason K; Ito M
Sci Rep; 2016 Jul; 6():29450. PubMed ID: 27377778
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
[TBL] [Abstract][Full Text] [Related]
59. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
[TBL] [Abstract][Full Text] [Related]
60. Lens capsule abnormalities in Alport's syndrome.
Streeten BW; Robinson MR; Wallace R; Jones DB
Arch Ophthalmol; 1987 Dec; 105(12):1693-7. PubMed ID: 3689194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
